Clinical Trial Update: Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating paroxetine plus bupropion for depression with suicidal ideation; results were posted in 2017 and included an fMRI study component.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicidal Ideation

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)
• bupropion (bupropion)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Depression, Suicidal Ideation | Phase 4 | Status: COMPLETED | Results posted: 2017-02-15